If you have ever wondered why some days feel more stressful than others even when you sleep well? In the recent development there’s exciting news from the world of health tech, Ultrahuman’s Next-Gen Wearables: Files Patent for Physiological Stress Monitoring System, introducing a smart real-time monitoring technology that tracks stress by analyzing your body’s natural … Read more
On Nov 5, 2025, the Patents Court handed down an important interim injunction decision in Dr Reddy’s Laboratories (UK) Ltd v Boehringer Ingelheim International GmbH, neutral citation EWHC 2834 (Pat). Michael Tappin KC, sitting as a Deputy Judge, granted interim relief restraining Dr Reddy’s from dealing in empagliflozin (the active in Jardiance) in the UK … Read more
In the case Merck Serono S.A. v. Hopewell Pharma Ventures, Inc., the Federal Circuit upheld a Patent Trial and Appeal Board decision invalidating claims related to Merck’s multiple sclerosis drug Mavenclad, an oral formulation of the compound Cladribine. Merck Serono S.A. v. Hopewell Pharma Ventures, Inc. – Basic Details: Merck Serono S.A. v. Hopewell Pharma … Read more
UK Court of Appeal Judgment on Dapagliflozin Patent UK Court of Appeal Judgment: Dapagliflozin Patent In a recent landmark judgment, the UK Court of Appeal upheld the High Court’s April 2025 decision invalidating the UK equivalent patent of EP1506211B1 (expired on May 14, 2023) for Dapagliflozin and its associated Supplementary Protection Certificate (SPC) (Expiry Date: … Read more
